drugset / Trial / NCT02783053

Metformin and Core Temperature in Obese and Lean Males

NCT02783053 ↗

Non-randomizedCrossoverOpen-labelDiagnostic

Summary

Metformin is known to increase 18F-FDG uptake in subjects using metformin in retrospective trials. In this study the researchers aim to investigate the influence of metformin (500 mg 1/day) on temperature in the colon, glucose uptake in the colon and energy expenditure in healthy lean (BMI \< 24kg/m2) or obese subjects (BMI\>28kg/m2). The investigators will measure 18F-FDG uptake in the colon, temperature in the colon, insulin sensitivity and energy expenditure before after using metformin.

Timeline

Start
2015-10
Primary completion
2016-06
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 500 mg —

Indications